Neuberger Berman Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $272M | Buy |
9,693,119
+2,331,465
| +32% | +$62.1M | 0.21% | 95 |
|
|
2025
Q4 | $183M | Sell |
7,361,654
-1,651,157
| -18% | -$41.6M | 0.14% | 165 |
|
|
2025
Q3 | $229M | Buy |
9,012,811
+6,045,763
| +204% | +$149M | 0.17% | 124 |
|
|
2025
Q2 | $71.9M | Buy |
2,967,048
+1,054,125
| +55% | +$24.6M | 0.06% | 386 |
|
|
2025
Q1 | $48.5M | Sell |
1,912,923
-3,032,970
| -61% | -$79.4M | 0.04% | 439 |
|
|
2024
Q4 | $131M | Sell |
4,945,893
-9,001,249
| -65% | -$244M | 0.1% | 234 |
|
|
2024
Q3 | $404M | Buy |
13,947,142
+149,492
| +1% | +$4.36M | 0.32% | 70 |
|
|
2024
Q2 | $386M | Sell |
13,797,650
-1,454,733
| -10% | -$40.1M | 0.32% | 71 |
|
|
2024
Q1 | $423M | Sell |
15,252,383
-2,449,966
| -14% | -$68M | 0.35% | 56 |
|
|
2023
Q4 | $510M | Buy |
17,702,349
+666,784
| +4% | +$20.2M | 0.44% | 44 |
|
|
2023
Q3 | $565M | Buy |
17,035,565
+3,292,002
| +24% | +$116M | 0.51% | 36 |
|
|
2023
Q2 | $504M | Sell |
13,743,563
-54,920
| -0.4% | -$2.14M | 0.45% | 42 |
|
|
2023
Q1 | $563M | Buy |
13,798,483
+1,456,337
| +12% | +$62.9M | 0.52% | 34 |
|
|
2022
Q4 | $632M | Sell |
12,342,146
-931,535
| -7% | -$44.7M | 0.62% | 19 |
|
|
2022
Q3 | $581M | Buy |
13,273,681
+1,061,894
| +9% | +$51.6M | 0.61% | 18 |
|
|
2022
Q2 | $640M | Buy |
12,211,787
+2,208,244
| +22% | +$113M | 0.64% | 16 |
|
|
2022
Q1 | $518M | Buy |
10,003,543
+499,802
| +5% | +$25.9M | 0.44% | 34 |
|
|
2021
Q4 | $556M | Buy |
9,503,741
+119,903
| +1% | +$5.94M | 0.44% | 39 |
|
|
2021
Q3 | $401M | Buy |
9,383,838
+828,318
| +10% | +$36.7M | 0.35% | 57 |
|
|
2021
Q2 | $334M | Buy |
8,555,520
+3,317,439
| +63% | +$129M | 0.29% | 76 |
|
|
2021
Q1 | $189M | Sell |
5,238,081
-1,039,370
| -17% | -$36.9M | 0.18% | 173 |
|
|
2020
Q4 | $231M | Sell |
6,277,451
-869,468
| -12% | -$31.9M | 0.24% | 115 |
|
|
2020
Q3 | $249M | Sell |
7,146,919
-557,377
| -7% | -$19.5M | 0.29% | 79 |
|
|
2020
Q2 | $239M | Sell |
7,704,296
-733,502
| -9% | -$24.9M | 0.3% | 86 |
|
|
2020
Q1 | $261M | Sell |
8,437,798
-754,398
| -8% | -$25.7M | 0.4% | 52 |
|
|
2019
Q4 | $342M | Sell |
9,192,196
-1,876,005
| -17% | -$66.8M | 0.4% | 47 |
|
|
2019
Q3 | $377M | Sell |
11,068,201
-1,200,184
| -10% | -$43.6M | 0.46% | 35 |
|
|
2019
Q2 | $504M | Sell |
12,268,385
-810,248
| -6% | -$32.2M | 0.6% | 22 |
|
|
2019
Q1 | $527M | Sell |
13,078,633
-980,639
| -7% | -$39.3M | 0.65% | 20 |
|
|
2018
Q4 | $582M | Sell |
14,059,272
-1,077,650
| -7% | -$44.7M | 0.81% | 9 |
|
|
2018
Q3 | $633M | Sell |
15,136,922
-862,806
| -5% | -$33.2M | 0.72% | 13 |
|
|
2018
Q2 | $551M | Sell |
15,999,728
-923,412
| -5% | -$31.6M | 0.61% | 20 |
|
|
2018
Q1 | $570M | Buy |
16,923,140
+2,564,060
| +18% | +$88.1M | 0.65% | 18 |
|
|
2017
Q4 | $494M | Sell |
14,359,080
-792,112
| -5% | -$27M | 0.57% | 22 |
|
|
2017
Q3 | $513M | Sell |
15,151,192
-689,574
| -4% | -$22.2M | 0.64% | 17 |
|
|
2017
Q2 | $505M | Sell |
15,840,766
-821,394
| -5% | -$25.9M | 0.65% | 16 |
|
|
2017
Q1 | $541M | Sell |
16,662,160
-3,302,443
| -17% | -$104M | 0.7% | 11 |
|
|
2016
Q4 | $615M | Sell |
19,964,603
-5,342,933
| -21% | -$163M | 0.83% | 7 |
|
|
2016
Q3 | $813M | Buy |
25,307,536
+117,283
| +0.5% | +$3.92M | 1.1% | 2 |
|
|
2016
Q2 | $842M | Sell |
25,190,253
-1,743,253
| -6% | -$55.6M | 1.16% | 2 |
|
|
2016
Q1 | $757M | Buy |
26,933,506
+4,393,679
| +19% | +$126M | 1.04% | 3 |
|
|
2015
Q4 | $690M | Sell |
22,539,827
-2,161,103
| -9% | -$68M | 0.9% | 3 |
|
|
2015
Q3 | $736M | Buy |
24,700,930
+747,984
| +3% | +$24M | 0.95% | 3 |
|
|
2015
Q2 | $762M | Sell |
23,952,946
-2,950,532
| -11% | -$96.2M | 0.85% | 6 |
|
|
2015
Q1 | $888M | Sell |
26,903,478
-1,429,665
| -5% | -$45.5M | 0.95% | 4 |
|
|
2014
Q4 | $837M | Sell |
28,333,143
-1,488,467
| -5% | -$42.7M | 0.87% | 7 |
|
|
2014
Q3 | $837M | Sell |
29,821,610
-2,485,742
| -8% | -$69.8M | 0.86% | 10 |
|
|
2014
Q2 | $910M | Buy |
32,307,352
+2,927,880
| +10% | +$83.5M | 0.89% | 9 |
|
|
2014
Q1 | $895M | Buy |
29,379,472
+929,047
| +3% | +$27.7M | 0.91% | 8 |
|
|
2013
Q4 | $827M | Sell |
28,450,425
-692,171
| -2% | -$20.1M | 0.85% | 11 |
|
|
2013
Q3 | $794M | Buy |
29,142,596
+589,266
| +2% | +$16M | 0.88% | 7 |
|
|
2013
Q2 | $759M | Buy |
+28,553,330
| New | +$789M | 0.9% | 7 |
|
Other funds holding PFE
VCM
VPM
Neuberger Berman Group's PFE Position: Q1 2026 in Review
Neuberger Berman Group increased its Pfizer (PFE) stake by 32% in Q1 2026, buying an estimated $62.1M and bringing the position to 9,693,119 shares worth $272M. The position accounts for 0.21% of the portfolio, ranked #95.
Neuberger Berman Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $910M in Q2 2014. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Neuberger Berman Group held 9,693,119 shares of Pfizer worth $272M as of Q1 2026.
- Neuberger Berman Group bought 2,331,465 Pfizer shares in Q1 2026, an estimated $62.1M.
- Pfizer made up 0.21% of Neuberger Berman Group's portfolio in Q1 2026, its #95 holding.
- Neuberger Berman Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Neuberger Berman Group's Pfizer position peaked at $910M in Q2 2014.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.